Get started
Work

Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma

Year: 2014
Type: conference-abstract
Abstract: Meeting abstracts There have been significant advances in the treatment of melanoma via the use of targeted therapy and immunotherapy, however a significant proportion of patients still progress on treatment. Intense research efforts are underway to better understand resistance, and multiple
DOI: 10.1186/2051-1426-2-s3-p200
Authors: Alexandre Reuben, Zachary A Cooper, Rodabe N Amaria, Marie A Forget, Cara Haymaker, Chantale Bernatchez, Pei-ling Chen, Michael T Tetzlaff, Lynda Chin, Karen C Dwyer, Jennifer A Wargo
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2017723298
Cites:
Cited by: 2
Related to: 10